Antitachycardia pacing programming in implantable cardioverter defibrillator: A systematic review

doi:10.4330/wjc.v9.i5.429

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 5

This Article

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (10210)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-2) series.

Item

Count

PDF

852

WORD

465

HTML

5905

Figures (1-1)

522

Tables (1-2)

518

Sum=8262

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

825

Download

1106

Sum=1931

May 26, 2017 (publication date) through Feb 17, 2026

Times Cited of This Article

Times Cited (19)

Journal Information of This Article

Publication Name

World Journal of Cardiology

ISSN

1949-8462

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Minireviews

World J Cardiol. May 26, 2017; 9(5): 429-436
Published online May 26, 2017. doi: 10.4330/wjc.v9.i5.429

Antitachycardia pacing programming in implantable cardioverter defibrillator: A systematic review

Elia De Maria, Daniele Giacopelli, Ambra Borghi, Letizia Modonesi, Stefano Cappelli

Elia De Maria, Ambra Borghi, Letizia Modonesi, Stefano Cappelli, Cardiology Unit, Ramazzini Hospital, 41012 Carpi (Modena), Italy

Daniele Giacopelli, Biotronik Italia, Dipartimento Clinico, 20090 Vimodrone, Italy

Author contributions: De Maria E and Giacopelli D contributed to concept/design, data analysis/interpretation, drafting the article, critical revision, approval; Borghi A, Modonesi L and Cappelli S contributed to drafting the article, critical revision, approval.

Conflict-of-interest statement: Daniele Giacopelli is a Biotronik employee. The other authors report no relationships that could be construed as a conflict of interest.

Correspondence to: Elia De Maria, MD, PhD, Chief of Arrhythmology Lab, Cardiology Unit, Ramazzini Hospital, Via Molinari 1, 41012 Carpi (Modena), Italy. e.demaria@inwind.it

Telephone: +39-05-9659320 Fax: +39-05-9659387

Received: November 14, 2016
Peer-review started: November 14, 2016
First decision: February 15, 2017
Revised: February 24, 2017
Accepted: March 12, 2017
Article in press: March 13, 2017
Published online: May 26, 2017
Processing time: 187 Days and 7.8 Hours

Core Tip

Core tip: Antitachycardia pacing (ATP) has a great importance in the treatment of ventricular arrhythmias, whether slow or fast. It reduces the number of unnecessary shocks and it improves both patient’s quality of life and device longevity. Beyond ATP use, excellent clinical results were obtained with programming standardization following these principles: Extended detection in ventricular fibrillation (VF) zone; supraventricular discrimination criteria up to 200 bpm; first shock in VF zone at the maximum energy in order to reduce the risk of multiple shocks. The MADIT-RIT trial and some registries have also recently demonstrated that programming with a widespread use of ATP, higher cut-off rates or delayed intervention reduces the number of inappropriate therapies and improves the survival of patients during medium term follow-up.